Any pharma company interested in the bait products could have bought them directly or easily made a better product. They don't need silly penny conmen in the middle, bringing their toxic debt overhang along for the ride. Get real, folks. There is nothing attractive about MDIN, unless you hold the keys to the ATM.
Market Data 
Markets 
AI
